Filgrastim biosimilar - Fuji Pharmaceutical/Mochida Pharmaceutical/Gene Techno Science

Drug Profile

Filgrastim biosimilar - Fuji Pharmaceutical/Mochida Pharmaceutical/Gene Techno Science

Alternative Names: Filgrastim BS; FSK-0808; GBS 001

Latest Information Update: 02 Apr 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fuji Pharmaceutical; Gene Techno Science; Mochida Pharmaceutical
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
  • Mechanism of Action Granulocyte colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Neutropenia

Most Recent Events

  • 08 Aug 2013 Biomarkers information updated
  • 15 Nov 2011 Biosimilar filgrastim is still in phase II/III trials for Neutropenia in Japan
  • 30 Jul 2010 Phase-II/III clinical trials in Neutropenia in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top